OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
August 02, 2006
The new drug user-fee program will define how FDA does business over its next 100 years.
July 02, 2006
FDA is conducting laboratory research to understand better the ability of preclinical screening tests to identify potential risks and toxicities of nanotechnology-based drugs.
June 02, 2006
ORA leadership looks to staff redeployment and risk management to ensure product quality despite diminishing resources.
May 02, 2006
Manufacturing and formulation innovation spurs drug develop-ment, but raises new safety and quality issues.
April 02, 2006
The need to curb drug counterfeiting is spurring development of track-and-trace and product authentication technologies.
March 16, 2006
Bush Administration Nominates von Eschenbach to head FDA